U.S. implant manufacturers have recently received FDA’s clearance for products manufactured with Arcam’s EBM® technology. With the FDA clearance the companies are allowed to market their products on the important U.S. market.
The U.S. market for orthopaedic implants represents about half of the world-wide implant market. Up to now U.S. sales of orthopaedic products manufactured with Arcam’s EBM ® technology have been limited to patient-specific implants, which do not require clearance. Arcam already has systems installed for orthopaedic applications at four U.S. companies. These recent FDA clearances open up a market with a large potential, and are a further confirmation that implants produced with the Arcam technology fulfil the high standards and demands in the orthopaedic implant industry.
PLUS, a new case study highlights of integrated tabecular structure for Fix Ti-Por acetabular cup.
New orthopaedic implants improve people’s quality of life
The CE-certified Fixa Ti-Por acetabular cup...Manufactured with an integrated trabecular structure for improved osseointegration.
Latest from Today's Medical Developments
- GrindingHub Americas launches in 2027 in Cincinnati, Ohio
- Methods Machine Tools now offers the Nakamura-Tome NT-Flex
- Battelle awards $900,000 in STEM education grants to Ohio schools
- #55 Lunch + Learn Podcast with KINEXON
- Starrett and Gerstner offer limited edition, American made 1950s replica wooden machinist tool chests
- EMCO’s UNIVERSALTURN 50: The new benchmark in universal turning
- Archetype's Expertise for Equity accelerates early-stage innovation
- Stratasys expands its AM solutions with Tritone's cutting-edge technology